content top

Clinical Experience of Ocriplasmin for Vitreomacular Traction and MH

Purpose: To evaluate the anatomical and functional results after ocriplasmin (JETREA, ThromboGenics NV, Iselin, NJ, USA) injection in patients with vitreomacular traction (VMT) with or without macular hole (MH). Methods: Fifteen prospective patients with VMT were treated with a single ocriplasmin injection and followed-up at baseline, 1 week, 1, 3 and 6 months. ETDRS best-corrected visual acuity (BCVA), intraocular pressure and...

Read More

Dome-shaped Macula in Non Myopic Patients; Description and Management

http://www.dailymotion.com/video/xuct5f http://www.dailymotion.com/video/xudmjn http://www.dailymotion.com/video/xufmom Advantages: Gaucher et al. described an unusual feature in myopic eyes responsible for visual loss called Dome-Shaped macula (D-Sh-M). This condition was defined as a convex elevation of macula within a staphyloma in highly myopic patients as diagnosed by OCT. Moreover, this entity was associated with RPE atrophic...

Read More
content top